Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-06

Clinical Trial Update: Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance [Phase 2]

View source ↗

Summary

Phase 2 trial comparing sacrosidase to placebo in subjects with fructan intolerance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • sacrosidase

Snippet

Sponsor: QOL Medical, LLC | Conditions: Fructan Intolerance | Phase 2 | Status: COMPLETED